Literature DB >> 16961972

Compound heterozygous CNGA3 mutations (R436W, L633P) in a Japanese patient with congenital achromatopsia.

Satoshi Goto-Omoto1, Takaaki Hayashi, Tamaki Gekka, Akiko Kubo, Tomokazu Takeuchi, Kenji Kitahara.   

Abstract

Congenital achromatopsia is a stationary retinal disorder with autosomal recessive inheritance that is characterized by loss of color discrimination, low visual acuity, photophobia, and nystagmus. This disorder has been shown to be associated with CNGA3, CNGB3, and GNAT2 mutations, and the frequency of mutations in the CNGA3 gene (encoding alpha subunit of the cone-specific cGMP-gated cation channel) was 23-33% in European populations. The aim of this study was to test the hypothesis that CNGA3 mutations are also responsible for congenital achromatopsia in Japanese patients. DNA from venous blood samples from a total of 14 patients from 13 Japanese pedigrees was prepared. Mutation screening of the CNGA3 gene was performed using direct sequencing and PCR-single-strand conformation polymorphism analysis. Compound heterozygous missense mutations (p.R436W and p.L633P, the latter of which was novel) were identified in one patient only, a 22-year-old female. Neither of these two mutations was found in 150 Japanese control individuals. The patient's parents and sister carried one of these mutations each but were not affected. No mutations in the CNGB3 or GNAT2 genes were identified in the patient. Clinically, best-corrected visual acuity was 0.1 in both eyes. No specific findings were obtained in funduscopy. Optical coherence topography revealed a normal foveal thickness but a 20% decrease in parafoveal thickness. Ganzfeld full-field electroretinograms (ERGs) showed normal responses in rod and mixed rod-plus-cone ERGs but no response in cone or 30-Hz flicker ERGs. Spectral sensitivity on a white background revealed a curve with only one peak at around 500 nm, which fits the absorption spectrum of human rhodopsin. L633, conserved among vertebrate orthologs of human CNGA3, is a hydrophobic residue forming part of the carboxy-terminal leucine zipper (CLZ) domain, which is functionally important in the mediation of intracellular interactions. To our knowledge, this is the first report of a Japanese complete achromat with CNGA3 mutations, and of any patient with a missense mutation within the CLZ domain. The outcome suggests low frequency (7%, 1/14) of CNGA3 mutations in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961972     DOI: 10.1017/S095252380623308X

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  15 in total

1.  Achromatopsia as a potential candidate for gene therapy.

Authors:  Ji-Jing Pang; John Alexander; Bo Lei; Wentao Deng; Keqing Zhang; Qiuhong Li; Bo Chang; William W Hauswirth
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Genetic analysis of four Pakistani families with achromatopsia and a novel S4 motif mutation of CNGA3.

Authors:  Muhammad Arif Nadeem Saqib; Bilal Malik Awan; Mehwish Sarfraz; Muhammad Nasim Khan; Sajid Rashid; Muhammad Ansar
Journal:  Jpn J Ophthalmol       Date:  2011-09-13       Impact factor: 2.447

3.  The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.

Authors:  Shannon E Boye; John J Alexander; Sanford L Boye; Clark D Witherspoon; Kristen J Sandefer; Thomas J Conlon; Kirsten Erger; Jingfen Sun; Renee Ryals; Vince A Chiodo; Mark E Clark; Christopher A Girkin; William W Hauswirth; Paul D Gamlin
Journal:  Hum Gene Ther       Date:  2012-09-20       Impact factor: 5.695

Review 4.  Function and dysfunction of CNG channels: insights from channelopathies and mouse models.

Authors:  Martin Biel; Stylianos Michalakis
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

5.  CNGA3 achromatopsia-associated mutation potentiates the phosphoinositide sensitivity of cone photoreceptor CNG channels by altering intersubunit interactions.

Authors:  Gucan Dai; Michael D Varnum
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

6.  Novel mutations in the gene for α-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia.

Authors:  Kazuki Kuniyoshi; Sanae Muraki-Oda; Hisao Ueyama; Futoshi Toyoda; Hiroyuki Sakuramoto; Hisakazu Ogita; Motohiro Irifune; Shuji Yamamoto; Akira Nakao; Kazushige Tsunoda; Takeshi Iwata; Masahito Ohji; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-02-05       Impact factor: 2.447

7.  Achromatopsia caused by novel missense mutations in the CNGA3 gene.

Authors:  Xi-Teng Chen; Hui Huang; Yan-Hua Chen; Li-Jie Dong; Xiao-Rong Li; Xiao-Min Zhang
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

8.  Disease-associated mutations in CNGB3 promote cytotoxicity in photoreceptor-derived cells.

Authors:  Chunming Liu; Tshering Sherpa; Michael D Varnum
Journal:  Mol Vis       Date:  2013-06-11       Impact factor: 2.367

9.  Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes.

Authors:  Worapoj Jinda; Aekkachai Tuekprakhon; Wanna Thongnoppakhun; Chanin Limwongse; Adisak Trinavarat; La-Ongsri Atchaneeyasakul
Journal:  Int Ophthalmol       Date:  2020-08-31       Impact factor: 2.031

10.  Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy.

Authors:  Sanford L Boye; Shreyasi Choudhury; Sean Crosson; Giovanni Di Pasquale; Sandra Afione; Russell Mellen; Victoria Makal; Kaitlyn R Calabro; Diego Fajardo; James Peterson; Hangning Zhang; Matthew T Leahy; Colin K Jennings; John A Chiorini; Ryan F Boyd; Shannon E Boye
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.